Pedro Leite-Silva is associated with the Cancer Epidemiology Group at the Research Center & Department of Epidemiology, Portuguese Institute of Oncology of Porto, located at Rua Dr. António Bernardino de Almeida 865, 4200-072 Porto, Portugal. His work appears to be focused on cancer research, particularly in the area of cancer progression, treatment responsiveness, and tumor heterogeneity.
Research Contributions
Pedro Leite-Silva has made significant contributions to the field of cancer research. Some of his notable works include studies on cadherin switches during epithelial-mesenchymal transition in bladder cancer, differential methylation analyses related to cisplatin resistance in testicular germ cell tumors, and the predictive value of promoter methylation of DNA homologous recombination genes for PARP inhibitor treatment responsiveness. Additionally, he has investigated the deregulation of N6-Methyladenosine RNA modification and its erasers in renal cell tumor subtypes.
Aliases
Pedro Leite-Silva is also known by the aliases "P. Leite-silva" and "P. Leite-Silva."
